title: [Remote results of angioplasty using drug-coated balloons in lesions of the femoropopliteal segment].
abstract: The authors analysed the results of balloon angioplasty using paclitaxel-coated balloons (IN.PACT Admiral, Medtronic Inc., USA) in patients with occlusive and stenotic lesions of arteries of the femoropopliteal segment. The Study Group was composed of 30 patients subjected to angioplasty with drug-coated balloons and the Control Group consisted of 32 patients undergoing balloon angioplasty with uncoated balloons. Primary patency of the angioplasty zone within the terms up to 30 months after the intervention using drug-coated balloons amounted to 70% and in the Control Group to 37.5%, with the limb-salvage rate equalling 96.7% and 87.5%, respectively. It was shown that angioplasty using drug-coated balloons in treatment of occlusive and stenotic lesions of femoropopliteal arteries considerably improves the results of treatment at the expense of preventing restenosis of the angioplasty zone both in the short- and long-term periods of follow up.
authors.forename: I I
authors.initials: II
authors.lastname: Zatevakhin
authors.forename: V N
authors.initials: VN
authors.lastname: Shipovskiĭ
authors.forename: S B
authors.initials: SB
authors.lastname: Tursunov
authors.forename: V E
authors.initials: VE
authors.lastname: Bagdat'ev
authors.forename: Sh R
authors.initials: ShR
authors.lastname: Dzhurakulov
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000792:Angiography / Q000379:methods; D000800:Angioplasty, Balloon / Q000295:instrumentation / Q000379:methods; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D004867:Equipment Design / Q000379:methods; D005260:Female; D005263:Femoral Artery / Q000473:pathology*; D005500:Follow-Up Studies; D006801:Humans; D007511:Ischemia / Q000209:etiology / Q000503:physiopathology; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000627:therapeutic use*; D011150:Popliteal Artery / Q000473:pathology*; D012426:Russia; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014654:Vascular Patency
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel